PET dioxin isotope dilution analysis is the definitive reference technique for quantifying polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) in polyethylene terephthalate at parts-per-trillion levels. By combining carbon-13 labeled internal standards with high-resolution gas chromatography and high-resolution mass spectrometry (HRGC/HRMS), the method provides the sensitivity, accuracy, and regulatory defensibility required for virgin PET resins, recycled PET (rPET), and food-contact packaging compliance worldwide.
Technical Overview
Polyethylene terephthalate (PET) is one of the most widely used thermoplastic polymers for beverage bottles, food trays, films, and fibers, prized for its clarity, barrier properties, and recyclability. Although PET itself is a chlorine-free polymer, dioxins (PCDDs) and furans (PCDFs) can be introduced or formed at trace levels through thermal processing at 250–300 °C in the presence of parts-per-million chlorine contamination, through carry-over of chlorinated residues such as PVC flakes, pesticides, or halogenated printing inks in post-consumer recycling streams, and through contaminated feedstock or process water. Because dioxins are persistent, bioaccumulative, and among the most toxic anthropogenic compounds known, their control in food-contact and recycled PET has become a key element of material safety assessment.
Isotope dilution is the internationally recognized gold-standard quantification strategy for dioxins. A known amount of carbon-13 labeled (13C12) analogues of the target congeners is added to the PET sample before any analytical manipulation. Because the labeled and native molecules behave identically during extraction, cleanup, and chromatography, the isotope ratio measured by mass spectrometry corrects automatically for matrix losses, providing far superior accuracy at femtogram levels compared with external calibration. Isotope dilution is coupled with high-resolution gas chromatography and double-focusing magnetic sector high-resolution mass spectrometry (HRGC/HRMS) operated at a resolving power of at least 10,000, which separates the analyte ions from complex polymer-derived interferences and delivers unambiguous confirmation of each congener.
The analytical scope covers the seventeen 2,3,7,8-substituted PCDD/F congeners regulated by the World Health Organization, with results expressed both as individual congener concentrations (pg/g) and as toxic equivalents (WHO-TEQ) calculated using the 2005 toxic equivalency factors. Detection limits in the sub-pg/g range are routinely achieved, enabling compliance verification against the most stringent industry and regulatory specifications for virgin and recycled PET.
Testing Samples
Virgin PET Resin and Pellets
Base resins, amorphous and crystallized pellets, and chip materials intended for direct food-contact applications, verifying that upstream polymerization, drying, and solid-state polycondensation have not generated or concentrated chlorinated aromatic contaminants.
Post-Consumer Recycled PET (rPET) Flakes and Granules
Hot-washed or cold-washed flake, regranulated rPET, and pellets from mechanical or super-clean recycling processes. This category carries the highest dioxin relevance because input streams may include PVC mis-sorting, chlorinated label adhesives, and pesticide-contaminated containers, and the material is re-melted during reprocessing.
PET Films, Sheets, and Thermoformed Containers
Biaxially oriented films, amorphous PET (APET/CPET) sheets, thermoformed trays, and lidding materials used for food packaging, tested to confirm compliance with food-contact safety requirements for retail and airline packaging programs.
PET Preforms, Bottles, and Closures
Finished and semi-finished packaging articles, including monolayer and multilayer structures containing rPET layers, evaluated as part of finished-product quality control and brand-owner specification release.
PET Fibers, Strapping, and Technical Grades
Testing Items
The core testing package comprises the seventeen toxic 2,3,7,8-chlorine-substituted congeners determined by isotope dilution HRGC/HRMS, together with the calculated WHO toxic equivalent (TEQ):
- 2,3,7,8-TCDD; 1,2,3,7,8-PeCDD; 1,2,3,4,7,8-HxCDD; 1,2,3,6,7,8-HxCDD; 1,2,3,7,8,9-HxCDD; 1,2,3,4,6,7,8-HpCDD; OCDD
- 2,3,7,8-TCDF; 1,2,3,7,8-PeCDF; 2,3,4,7,8-PeCDF; 1,2,3,4,7,8-HxCDF; 1,2,3,6,7,8-HxCDF; 1,2,3,7,8,9-HxCDF; 2,3,4,6,7,8-HxCDF; 1,2,3,4,6,7,8-HpCDF; 1,2,3,4,7,8,9-HpCDF; OCDF
- Sum of PCDDs, sum of PCDFs, and total WHO-TEQ (2005 TEFs), upper-bound and lower-bound values
- Optional extensions: the twelve dioxin-like PCBs (WHO-PCB TEQ), total organic chlorine screening, and brominated dioxin (PBDD/F) packages for specialized risk assessments
Labeled compound recoveries for all 13C surrogates, extraction internal standards, and recovery (sampling) standards are reported for every sample, providing full transparency on method performance.
Testing Methods
Method Basis and Applicable Standards
Testing is performed in accordance with internationally recognized isotope dilution dioxin methodology, principally US EPA Method 1613B (Tetra- through Octa-Chlorinated Dioxins and Furans by Isotope Dilution HRGC/HRMS) and US EPA Method 8290A, adapted and validated for the PET polymer matrix. The approach is harmonized with the analytical conventions of EN 1948, Commission Regulation (EU) 2017/644, and national food-contact safety frameworks so that results are directly comparable with regulatory and customer benchmarks.
Sample Preparation and Extraction
A representative sample of 10–50 g is cryogenically milled to increase surface area. The powder is spiked with a certified 13C12-labeled surrogate solution covering all seventeen target congeners before extraction. PET is then extracted either by accelerated solvent extraction or Soxhlet extraction with toluene, or by complete dissolution in a hot PET-specific solvent such as hexafluoroisopropanol followed by polymer precipitation and back-extraction into nonane, ensuring quantitative release of bound PCDD/Fs.
Multistage Cleanup
The crude extract undergoes rigorous cleanup to remove polymer oligomers, additives, pigments, and chlorinated interferences. A typical sequence comprises multi-layer acidic/neutral/basic silica gel, Florisil, basic alumina, and a dispersed carbon (AX-21/Celite) column that traps planar PCDD/Fs, which are subsequently recovered by reversed-flow elution with toluene. The final extract is concentrated and transferred to vials containing the 13C-labeled recovery standard for injection.
HRGC/HRMS Instrumental Analysis
Analysis is performed on a 60 m low-bleed capillary column (DB-5MS or equivalent, 0.25 mm ID, 0.25 µm film) coupled to a double-focusing magnetic sector mass spectrometer operated in electron ionization (EI) mode at a resolving power of at least 10,000 (10% valley). The MS is operated in selected ion monitoring of the molecular ion and M+2 cluster for each chlorination homolog, with continuous lock-mass correction. Congener identification requires correct retention time within the established window, simultaneous detection of both quantitation ions, chlorine isotope ion ratios within ±15% of theoretical values, and signal-to-noise criteria of at least 3:1.
Calibration, Quantification, and TEQ Calculation
Quantification uses a multi-point isotope dilution calibration curve (minimum five levels) establishing relative response factors for each congener against its labeled analogue. Native congener amounts are derived from isotope ratio measurements, blank-corrected, and normalized to sample mass. Toxic equivalents are computed by multiplying each congener by its WHO-2005 TEF and summing, with both lower-bound (non-detects = 0) and upper-bound (non-detects = LOQ) TEQ values reported to satisfy conservative risk-assessment practices.
Quality Assurance and Quality Control
Each analytical batch includes a laboratory blank, an ongoing precision and recovery (OPR) sample, a duplicate sample, and certified reference material or matrix spike where available. Typical acceptance criteria include labeled compound recoveries of 40–135%, OPR results within established control limits, and blank contributions below one-third of the level observed in samples. Method detection limits generally range from 0.01 to 0.5 pg/g per congener, with practical quantification limits of 0.1–1.0 pg/g depending on sample intake. All data are reviewed under ISO/IEC 17025-aligned quality systems, with full chromatograms, ion ratios, and recovery data archived for audit.
Applications
Isotope dilution dioxin analysis of PET supports decision-making across the entire packaging value chain:
- Recycling process validation and EFSA-style safety dossiers for super-clean rPET technologies, supporting authorization under regulations such as Commission Regulation (EU) 2022/1616 on recycled plastic food-contact materials
- Incoming quality control of rPET flake and pellets by converters, bottle makers, and sheet extruders against internal or brand-owner TEQ specifications
- Regulatory compliance demonstration for food-contact materials in the EU (GMP under Regulation (EC) No 2023/2006), the United States (FDA 21 CFR 177.1630 and FDA recycling guidance), China (GB 4806 series framework), and other export markets
- Due diligence for recycled-content claims, eco-label certifications, and sustainability reporting programs requiring trace-contaminant screening
- Investigation of contamination incidents, supplier qualification, comparison of washing and decontamination technologies, and research into dioxin formation behavior during PET melt reprocessing
- Support for risk assessments in technical applications such as PET fibers for hygiene-sensitive textiles and pharmaceutical packaging components
FAQ
Q: PET contains no chlorine, so why test it for dioxins?
A: Although PET is chlorine-free, trace chlorine from PVC mis-sorting, chlorinated adhesives, inks, or pesticide residues can enter recycling streams, and melt reprocessing at 250–300 °C provides conditions for PCDD/F formation or enrichment. Dioxin testing of rPET is therefore a recognized component of recycled-material safety evaluation and many commercial specifications.
Q: What detection capability does isotope dilution HRGC/HRMS provide for PET?
A: With adequate sample intake (10–50 g), method detection limits of 0.01–0.5 pg/g per congener are routinely achieved, corresponding to low pg WHO-TEQ/kg reporting capability—sufficient for the most demanding food-contact and brand specifications.
Q: How much sample is required and what is the typical turnaround time?
A: A minimum of 20–50 g of flakes, pellets, or milled article material is recommended, with additional material for duplicates or retesting. Standard turnaround is 10–15 working days after sample receipt, subject to queue and batch scheduling.
Q: Why is isotope dilution preferred over external calibration or screening bioassays?
A: Isotope dilution corrects for analyte losses throughout the multi-day analytical process and is the reference quantification approach mandated by EPA 1613B and equivalent international methods. Screening tools such as CALUX bioassays or GC-MS/MS can flag samples, but positive findings must be confirmed and quantified congener-by-congener by isotope dilution HRGC/HRMS for regulatory acceptance.
Q: How are results reported?
A: Reports present individual congener concentrations with detection flags, sum parameters (PCDD, PCDF, and total WHO-TEQ at lower- and upper-bound), labeled standard recoveries, ion-ratio acceptance, and clear comparison against any client-specified limit, accompanied by full QC documentation.
Q: Can the method be extended beyond the seventeen PCDD/F congeners?
A: Yes. Most laboratories offer parallel packages for the twelve dioxin-like PCBs (combined WHO-TEQ), brominated dioxins and furans, and non-ortho PCBs using the same isotope dilution HRGC/HRMS platform, providing a comprehensive halogenated-aromatics profile of PET materials.